Volume 98, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



The prevalence of hepatitis C virus (HCV) infection in the Kenyan population has not been previously determined. We estimated the Kenyan HCV prevalence in HIV-negative persons aged 15–64 years. This is a retrospective cross-sectional study using data from the 2007 Kenya AIDS Indicator Survey—a nationally representative sample of 15,853 persons aged 15–64 years who completed a health interview and provided a blood specimen. Of the 1,091 randomly selected participants, 50 tested positive for HCV antibody using the automated chemiluminescence immunoassay, corresponding to a weighted HCV antibody positivity rate of 4.4% (95% confidence interval: 3.3–5.9%) or 848,000 (range: 634,000–1,100,000) persons. Hepatitis C virus RNA, a marker for current infection, was not detected in any of the tested antibody-positive specimens. The high HCV antibody prevalence together with no current infection suggests that some HCV antibody serologic testing in Kenya may result in false positives whereas others may be because of spontaneous viral clearance.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Hanafiah KM, Groeger J, Flaxman AD, Wiersma ST, 2013. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57: 13331342.
    [Google Scholar]
  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggrawal R, Ahn SY, 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analyusis for the Global Burden of Disease Study 2010. Lancet 380: 20952125.
    [Google Scholar]
  3. Liang T, Rehermann B, Seeff L, Hoofnagle J, 2000. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132: 296305.
    [Google Scholar]
  4. Jehuda-Cohen T, Unal S, 2012. The challenges of hepatitis C diagnosis and the potential role of stimmunology to address them. Antivir Ther 17: 14151422.
    [Google Scholar]
  5. Chasela CS et al., 2012. Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. J Clin Virol 54: 318320.
    [Google Scholar]
  6. Mullis CE et al., 2013. High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clin Infect Dis 57: 17471750.
    [Google Scholar]
  7. Andonov A, Songok E, Ochwoto M, Osiowy C, Ball TB, 2015. HIV and hepatitis C virus co-infection in Kenya. Lancet Infect Dis 15: 13771378.
    [Google Scholar]
  8. Mwangi J et al., 2016. Hepatitis C virus genotypes in Kenya. Arch Virol 161: 95101.
    [Google Scholar]
  9. AASLD/IDSA Guidance Panel; Chung RT et al., 2015. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 62: 932954.
    [Google Scholar]
  10. World Health Organization, 2016. Guidelines for the Screening, Care, and Treatment of Persons with Hepatitis C Infection. Available at: https://www.ncbi.nlm.nih.gov/books/NBK362924/. Accessed January 6, 2016.
  11. National AIDS and STI Control Programme (Kenya), CDC Kenya, Centers for Disease Control and Prevention, (U.S.), Joint United Nations Programme on HIV/AIDS, United States Agency for International Development, U.S. President’s Emergency Plan for AIDS Relief, World Health Organization, 2009. Kenya AIDS Indicator Survey 2007: Final Report. Available at: http://stacks.cdc.gov/view/cdc/12122/Share. Accessed June 22, 2015.
  12. Centers for Disease Control and Prevention (U.S.), 2011. Viral Hepatitis Laboratory Testing, Available at: https://www.cdc.gov/hepatitis/hcv/labtesting.htm. Accessed January 10, 2018.
  13. Mixson-Hayden T, Lee D, Ganova-Raeva L, Drobeniuc J, Stauffer WM, Teshale E, Kamili S, 2014. Hepatitis B virus and hepatitis C virus infections in United States-bound refugees from Asia and Africa. Am J Trop Med Hyg 90: 10141020.
    [Google Scholar]
  14. The World Bank, 2015. Population Ages 15–64 (% of Total). Available at: http://data.worldbank.org/indicator/SP.POP.1564.TO.ZS/countries?page=1. Accessed April 16, 2015.
  15. Layden JE et al., 2015. High frequency of active HCV infection among seropositive cases in west Africa and evidence for multiple transmission pathways. Clin Infect Dis 60: 10331041.
    [Google Scholar]
  16. Basavaraju SV et al., 2010. Reduced risk of transfusion-transmitted HIV in Kenya through centrally co-ordinated blood centres, stringent donor selection and effective p24 antigen-HIV antibody screening. Vox Sang 99: 212219.
    [Google Scholar]
  17. Seremba E, Ocama P, Opio CK, Kagimu M, Thomas DL, Yuan HJ, Attar N, Lee WM, 2010. Poor performance of hepatitis C antibody tests in hospital patients in Uganda. J Med Virol 82: 13711378.
    [Google Scholar]
  18. Mayer D, 2004. Bayes’ theorem, predictive values, post-test probabilities, and interval likelihood ratios. Essential Evidence-Based Medicine, Chapter 24. Cambridge, United Kingdom: Cambridge University Press.
  19. Apata IW, Averhoff F, Pitman J, Bjork A, Yu J, Amin NA, Dhingra N, Kolwaite A, Marfin A; Centers for Disease Control and Prevention (CDC), 2014. Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection—sub-Saharan Africa, 2000–2011. MMWR Morb Mortal Wkly Rep 63: 613619.
    [Google Scholar]

Data & Media loading...

  • Received : 24 Oct 2017
  • Accepted : 23 Feb 2018
  • Published online : 23 Apr 2018
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error